Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Magro CM, Sanders S. Tumor necrosis factor ALPHA Inhibitor Associated Köhlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis. Am J Dermatopathol. 2024;46(9):605-610.

Bergom HE, Sena LA, Day A, Miller B, Miller CD, Lozada JR, et al. Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. NPJ Genom Med. 2024;9(1):7.

Zhang BX, Brantley KD, Rosenberg SM, Kirkner GJ, Collins LC, Ruddy KJ, et al. Second primary non-breast cancers in young breast cancer survivors. Breast Cancer Res Treat. 2024;207(3):587-597.

Magro C, Tili E, Nuovo G. Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. . Acta Neuropathol. 2024;147(1):47.

Gardner EE, Earlie EM, Li K, Thomas J, Hubisz MJ, Stein BD, et al. Lineage-specific intolerance to oncogenic drivers restricts histological transformation. Science. 2024;383(6683):eadj1415.

Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, et al. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. J Natl Cancer Inst. 2024;116(1):115-126.

Jain D, Khandakar B, Ni P, Kenney B, Qin L, Deshpande V, et al. von Meyenburg complexes are more frequently associated with cholangiocarcinoma. J Clin Pathol. 2024.

Cung M, Sosa B, Yang HS, McDonald MM, Matthews BG, Vlug AG, et al. The performance of artificial intelligence chatbot large language models to address skeletal biology and bone health queries. J Bone Miner Res. 2024.

Thomson AL, Suhardi VJ, Niu Y, Oktarina A, Döring K, Chao C, et al. A translational murine model of aseptic loosening with osseointegration failure. J Orthop Res. 2024;42(11):2525-2534.

Wheeler AP, Snyder EL, Refaai MA, Cohn CS, Poisson J, Fontaine MJ, et al. Acute Pulmonary Injury in Hematology Patients Supported with Pathogen Reduced and Conventional Platelet Components. Blood Adv. 2024.